60 related articles for article (PubMed ID: 25844440)
1. [Periplasmic lysozime inhibitior PliC and its role in antilysozime activity of enterobacteria].
Andryushenko SV; Perunova NB; Bukharin OV
Mikrobiologiia; 2014; 83(3):302-11. PubMed ID: 25844440
[TBL] [Abstract][Full Text] [Related]
2. [Genetic determinants of secreted lysozyme inhibitors and enterobacteria anti-lysozyme phenotype].
Perunova NB; Andriushchenko SV; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2012; (6):8-12. PubMed ID: 23297624
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of bacterial defense against host lysozymes: X-ray structures of periplasmic lysozyme inhibitors PliI and PliC.
Leysen S; Van Herreweghe JM; Callewaert L; Heirbaut M; Buntinx P; Michiels CW; Strelkov SV
J Mol Biol; 2011 Feb; 405(5):1233-45. PubMed ID: 21146533
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the inhibition of human lysozyme by PliC from Brucella abortus.
Um SH; Kim JS; Kim K; Kim N; Cho HS; Ha NC
Biochemistry; 2013 Dec; 52(51):9385-93. PubMed ID: 24308818
[TBL] [Abstract][Full Text] [Related]
5. [Frequency of occurrence of ivyC and pliC lysozyme inhibitors genes in clinical klebsiella strains].
Fialkina SV; Bondarenko VM; Rabaev IB; Nikolaeva IV; Semenova DR
Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):3-7. PubMed ID: 25286520
[TBL] [Abstract][Full Text] [Related]
6. [ACID-BASE MODULATION OF LYSOZYME ACTIVITY IN MEDIUM FOR CULTIVATION OF ENTEROBACTERIA].
Andryuschenko SV; Perunova NB
Zh Mikrobiol Epidemiol Immunobiol; 2015; (4):45-8. PubMed ID: 26470418
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of the Klebsiella pneumoniae waa gene cluster, involved in core lipopolysaccharide biosynthesis.
Regué M; Climent N; Abitiu N; Coderch N; Merino S; Izquierdo L; Altarriba M; Tomás JM
J Bacteriol; 2001 Jun; 183(12):3564-73. PubMed ID: 11371519
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of Klebsiella pneumoniae plasmid bearing the markers of drug resistance and antilysozyme activity].
Bondarenko VM; Iablochkov AL; Romanova IuM; Petrovskaia VG
Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):28-32. PubMed ID: 2838989
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of the PliG lysozyme inhibitor family.
Leysen S; Vanderkelen L; Van Asten K; Vanheuverzwijn S; Theuwis V; Michiels CW; Strelkov SV
J Struct Biol; 2012 Oct; 180(1):235-42. PubMed ID: 22634186
[TBL] [Abstract][Full Text] [Related]
10. Identification of basic amino acid residues important for citrate binding by the periplasmic receptor domain of the sensor kinase CitA.
Gerharz T; Reinelt S; Kaspar S; Scapozza L; Bott M
Biochemistry; 2003 May; 42(19):5917-24. PubMed ID: 12741850
[TBL] [Abstract][Full Text] [Related]
11. Transposition of IS1397 in the family Enterobacteriaceae and first characterization of ISKpn1, a new insertion sequence associated with Klebsiella pneumoniae palindromic units.
Wilde C; Bachellier S; Hofnung M; Clément JM
J Bacteriol; 2001 Aug; 183(15):4395-404. PubMed ID: 11443073
[TBL] [Abstract][Full Text] [Related]
12. Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors.
Voet A; Callewaert L; Ulens T; Vanderkelen L; Vanherreweghe JM; Michiels CW; De Maeyer M
Biochem Biophys Res Commun; 2011 Feb; 405(4):527-32. PubMed ID: 21256115
[TBL] [Abstract][Full Text] [Related]
13. [The antilysozyme factor in Klebsiella pneumoniae: its nature, biological functions and genetic control].
Bondarenko VM; Petrovskaia VG; Iablochkov AL
Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():22-8. PubMed ID: 7856342
[TBL] [Abstract][Full Text] [Related]
14. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW
Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551
[No Abstract] [Full Text] [Related]
15. [Effect of bifidobacteria on the anti-lysozyme activity of enterobacteria].
Valyshev AV; Elagina NN; Kirillov VA; Kirillov DA; Bukharin OV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):77-9. PubMed ID: 12712520
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and characteristics of Klebsiella pneumoniae lysozyme factor].
Iablochkov AL
Zh Mikrobiol Epidemiol Immunobiol; 1989 Feb; (2):11-4. PubMed ID: 2658433
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of the contribution of the small plasmids in creation of ESBL phenotype among clinical and ambulatory isolates of the Enterobacteriaceae].
Nieradko J
Med Dosw Mikrobiol; 2007; 59(3):223-30. PubMed ID: 18078117
[TBL] [Abstract][Full Text] [Related]
18. Comparison between plasmids of Salmonella and other enterobacteria isolated from the same patients.
Palomares JC; Perea EJ
Ann Microbiol (Paris); 1982; 133(2):301-10. PubMed ID: 6282161
[TBL] [Abstract][Full Text] [Related]
19. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Yang J; Luo Y; Cui S; Wang W; Han L
Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
[TBL] [Abstract][Full Text] [Related]
20. [The antilysozyme activity of bacteria in the genus Klebsiella].
Turianitsa AI; Boĭko NV
Mikrobiol Zh (1978); 1990; 52(1):20-2. PubMed ID: 2191198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
